Search filters

List of works by Shahin Akhondzadeh

A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia

scientific article published on 7 August 2008

A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease

scientific article published on 20 October 2009

A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders

scientific article published in October 2012

A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder

scientific article published on 11 October 2007

A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia.

scientific article

A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia.

scientific article published on December 2010

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.

scientific article

A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression

scientific article published on 10 October 2019

A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.

scientific article

A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia

scientific article published on 24 September 2011

A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.

scientific article published on 12 May 2009

A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients

scientific article published on 16 November 2013

Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial

scientific article published on 01 June 2011

Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial

scientific article

Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial

scientific article published in September 2003

Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial

scientific article published on 30 January 2007

Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial

scientific article published on 01 October 2006

Amantadine as adjuvant therapy in the treatment of moderate to severe obsessive-compulsive disorder: A double-blind randomized trial with placebo control

scientific article published on 25 December 2018

Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial

scientific article

Antidepressant-like effect of magnetic resonance imaging-based stimulation in mice.

scientific article

Aspirin for treatment of lithium-associated sexual dysfunction in men: randomized double-blind placebo-controlled study

scientific article published on 8 August 2013

Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial

scientific article published on 12 April 2019

Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial

scientific article published in February 2001

Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.

scientific article published on 28 December 2004

Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study

scientific article published on 01 July 2012

Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial.

scientific article published on 20 August 2015

Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial

scientific article

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial

scientific article published on 11 July 2012

Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial.

scientific article published on 6 May 2015

Celecoxib for the treatment of mild-to-moderate depression due to acute brucellosis: a double-blind, placebo-controlled, randomized trial

scientific article published on 26 May 2015

Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study

scientific article

Citicoline (CDP-choline) add-on therapy to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial

scientific article published on 14 June 2018

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

scientific article published in January 2009

Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial

scientific article published on 01 April 1998

Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study

scientific article published in March 2014

Comparing the effects of high-dose vitamin E with those of placebo on insulin resistance in patients with schizophrenia treated with olanzapine.

scientific article

Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial

scientific article published in July 2014

Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]

scientific article

Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial

scientific article published in February 2003

Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial

scientific article published in April 2005

Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial.

scientific article

Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double-blind randomized trial

scientific article published on 18 May 2020

Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia

scientific article published on 20 March 2006

Correlation of adenosinergic activity with superior efficacy of clozapine for treatment of chronic schizophrenia: a double blind randomised trial

scientific article published on 16 March 2011

Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial.

scientific article

Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.

scientific article

Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial

scientific article published in February 2005

Cyproheptadine for prevention of neuropsychiatric adverse effects of efavirenz: a randomized clinical trial

scientific article

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

scientific article published in April 2004

Cyproheptadine in treatment of autism.

scientific article published in July 2002

Cyproheptadine in treatment of chronic schizophrenia: a double-blind, placebo-controlled study

scientific article published on 01 February 1999

Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia

scientific article published in December 2002

Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions

scientific article published on 01 April 2000

Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression

scientific article published on 19 September 2012

Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression

scientific article published in October 2003

Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.

scientific article published on 20 September 2009

Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal

scientific article published in October 2000

Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.

scientific article published on 24 February 2011

Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study

scientific article published in November 2013

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder

scientific article published on 14 July 2010

Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania ⬇️

scientific article published on September 16, 2010

Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial

scientific article

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study

scientific article published on 18 April 2012

Effect of omega-3 and ascorbic acid on inflammation markers in depressed shift workers in Shahid Tondgoyan Oil Refinery, Iran: a randomized double-blind placebo-controlled study

scientific article

Effect of ritanserin, a 5HT2A/2C antagonist, on negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

scientific article

Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial

scientific article published on 3 May 2012

Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study

scientific article published on 19 February 2014

Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial

scientific article published on 03 August 2019

Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial

scientific article published on 27 November 2020

Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial

scientific article

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

scientific article published in March 2008

Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial

scientific article published in April 2004

Fluticasone propionate in clinically suspected asthma patients with negative methacholine challenge test.

scientific article

Fluvoxamine combination therapy with tropisetron for obsessive-compulsive disorder patients: A placebo-controlled, randomized clinical trial

scientific article published on 01 October 2019

Folinic Acid as Adjunctive Therapy in Treatment of Inappropriate Speech in Children with Autism: A Double-Blind and Placebo-Controlled Randomized Trial

scientific article published on 07 October 2020

Frequency of myasthenic crisis in relation to thymectomy in generalized myasthenia gravis: a 17-year experience

scientific article

Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.

scientific article

Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.

scientific article published on 5 October 2009

Glutamate-independent long term depression in rat hippocampus by activation GABAA receptors

scientific article published in January 1996

Glutathione-related factors and oxidative stress in autism, a review

scientific article

Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial

scientific article published on 01 October 2012

Granisetron as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study.

scientific article published on 30 January 2013

Health-related quality of life of Iranian children with attention deficit/hyperactivity disorder

scientific article published on 05 August 2010

Herbal medicine in the treatment of Alzheimer's disease.

scientific article

Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial

scientific article published on 6 January 2005

Hydroxyzine may be safe and effective in generalised anxiety disorder

scientific article published on 01 August 2003

Interaction between adenosine and GABAA receptors on hippocampal neurones

scientific article published on 01 December 1994

Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial

scientific article published on 25 February 2014

Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study

scientific article published in January 2013

L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study

scientific article published on 8 May 2017

L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial

scientific article

Lipoid proteinosis: phenotypic heterogeneity in Iranian families with c.507delT mutation in ECM1.

scientific article published in March 2015

Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial

scientific article published on 27 June 2014

Maintenance of muscimol-induced long-term depression by neurosteroids

scientific article published in February 1996

Major depressive disorder in children and adolescents after renal transplantation.

scientific article published in June 2009

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial

scientific article

Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study.

scientific article published on 9 October 2012

Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study.

scientific article published in June 2013

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

scientific article

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study

scientific article

Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial

scientific article published on 8 August 2007

Muscimol-induced long-term depression in the hippocampus: lack of dependence on extracellular calcium

scientific article

N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study.

scientific article

Omega-3 supplementation effects on body weight and depression among dieter women with co-morbidity of depression and obesity compared with the placebo: A randomized clinical trial

scientific article published on 17 March 2018

Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder

scientific article published on 01 November 2014

Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.

scientific article published on 16 October 2012

Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam

scientific article published on 01 October 2001

Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial

scientific article published in October 2001

Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches.

scientific article published on February 2007

Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double-blind, placebo-controlled trial.

scientific article published on 23 January 2015

Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.

scientific article

Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia

scientific article published on 01 October 1999

Potentiation by neurosteroids of muscimol/adenosine interactions in rat hippocampus

scientific article published in April 1995

Potentiation of muscimol-induced long-term depression by benzodiazepines and prevention or reversal by pregnenolone sulfate

scientific article published in December 1998

Potentiation of muscimol-induced long-term depression by benzodiazepines but not zolpidem

scientific article

Preface

Preface to a supplement to Pharmacy World on the 5TH Symposium of the European Society for the Study of Purine & Pyrimidtne Metabolism in Man (ESSPPMM 1995)

Prevalence of obsessive-compulsive disorder in Iran

scientific article

Prevention of muscimol-induced long-term depression by brain-derived neurotrophic factor

scientific article published on 01 October 1999

Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients

scientific article

Published research on attention deficit hyperactivity disorder: a comparative analysis of MEDLINE and an Iranian bibliographic database

scientific article published on 01 June 2010

Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial

scientific article

Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial

scientific article published on 24 May 2020

Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial

scientific article published on 12 November 2019

Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial

scientific article

Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial

scientific article published on 11 December 2018

Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial

scientific article

Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial

scientific article published on 4 October 2012

Role of melatonin in body weight: A systematic review and meta-analysis.

scientific article published on 29 November 2016

Saffron for treatment of fluoxetine-induced sexual dysfunction in women: randomized double-blind placebo-controlled study

scientific article

Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.

scientific article

Saffron, passionflower, valerian and sage for mental health.

scientific article published on March 2013

Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial

scientific article

Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial

scientific article published on 11 October 2013

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

scientific article published on 15 October 2010

Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial

scientific article published on 31 March 2015

Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial

scientific article published on 7 May 2015

Sudden hearing loss subsequent to diarrhea: what is the missing link?

scientific article

Sulforaphane as an adjunctive treatment for irritability in Autism Spectrum Disorder: a randomized, double-blind, placebo-controlled clinical trial

scientific article published on 29 April 2020

The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial

scientific article published on 2 December 2009

The glutamate hypothesis of schizophrenia

scientific article published on 01 August 1998

Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial

scientific article published on 13 October 2015

Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial

scientific article published on 24 May 2014

Total antioxidant capacity and malondialdehyde in depressive rotational shift workers

scientific article

Variations in thyroidal activity during estrous cycle and natural breeding season in Markhoz goat breeds

scientific article published in November 2009

Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial

scientific article published on 22 September 2010

Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial

scientific article published on 02 March 2020

Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double-blind, placebo-controlled trial

scientific article published on 05 September 2019

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]

scientific article

Paulina is supported by:

About Paulina

Help